EU

CND Intersessional Meeting

Chair: First and foremost, I would like to welcome you to the first intersessional meeting of a CND during this ssession. To start, I want to ensure that we’re aligned on the significant matters we’ve encountered, particularly regarding the outcome document. First of all though, the floor is the Secretariat’s. Secretariat:  Thank you, Mr. Chair. Good …

Read more

CND Tematic Discussion / Session 12 – Way Forward

Chair: I am grateful for your cooperation earlier this year. We had previously discussed the Resolution, outlining the review process, and collectively decided to convene before he regular committee session. The high-level segment is scheduled for March 14th and 15th, dedicated to assessing the implementation of international drug policy commitments. During this segment, we aim …

Read more

CND Thematic Discussion / Session 11 – Low availability of internationally controlled substances for medical & scientific purposes

Chair: Good Morning. Yesterday we had a fruitful discussion on the issues of the consequences and risk associated with non medical use of drugs. Today we will be discussing the low availability of nationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care. Before we start a discussion, …

Read more

CND Thematic Discussions // Session 8 – High transmission of HIV, HCV and other blood-borne diseases associated with drug use

Presenter 1, UNODC: Thank you, Mr. Chair, excellencies, ladies, and gentlemen. I will briefly discuss the lessons learned in the actual UNODC Partnership Project addressing drug use issues in Afghanistan amid the continuing humanitarian crisis. The project received funding support from the European Union for the implementation period 2023 to 2026. Addressing existing fragilities, including …

Read more